S&P・Nasdaq 本質的価値 お問い合わせ

Actinium Pharmaceuticals, Inc. ATNM NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.07
+778.6%

合計 50 件の最近のインサイダー取引記録が記録されています Actinium Pharmaceuticals, Inc. (ATNM), 内訳は 41 件の買い および 8 件の売り. インサイダー買い総額は $16.44M インサイダー売り総額は $2.15M.

最近活動のある主要インサイダーには Seth Sandesh, Steinhart Richard I, Almenoff June Sherie. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — ATNM

日付 氏名 役職 取引種別 株数 平均価格 価値 保有株数
2025-08-18 Seth Sandesh Chief Executive Officer RSU 源泉徴収 120,900 $1.71 $206.74K 184,481
2025-03-31 Steinhart Richard I Director 株式返還 2,500 $59.70 $149.25K -
2025-03-31 Almenoff June Sherie Director 株式返還 50,000 $1.71 $85.5K -
2025-03-31 Seth Sandesh Chief Executive Officer 株式返還 33,333 $23.49 $782.99K -
2025-03-31 O'loughlin Steve Chief Financial Officer 株式返還 3,333 $41.70 $138.99K -
2025-03-31 Nicholson, C. David Director 株式返還 70,311 $5.00 $351.56K -
2025-03-31 Shetty Ajit Director 株式返還 72,156 $4.96 $357.89K -
2025-03-31 Chell Jeffrey W. Director 株式返還 8,333 $9.55 $79.58K -
2024-11-01 Almenoff June Sherie Director 不明 - - - -
2024-11-01 Almenoff June Sherie Director RSU 付与(制限付株式) 50,000 $1.71 $85.5K 50,000
2023-12-28 Steinhart Richard I Director RSU 付与(制限付株式) 70,311 $5.00 $351.56K 70,311
2023-12-28 Seth Sandesh Chief Executive Officer RSU 付与(制限付株式) 984,367 $5.00 $4.92M 984,367
2023-12-28 O'loughlin Steve Chief Financial Officer RSU 付与(制限付株式) 253,123 $5.00 $1.27M 253,123
2023-12-28 Nicholson, C. David Director RSU 付与(制限付株式) 70,311 $5.00 $351.56K 70,311
2023-12-28 Shetty Ajit Director RSU 付与(制限付株式) 70,311 $5.00 $351.56K 70,311
2023-12-28 Chell Jeffrey W. Director RSU 付与(制限付株式) 70,311 $5.00 $351.56K 70,311
2022-08-17 Seth Sandesh Chief Executive Officer RSU 付与(制限付株式) 300,000 - - 305,381
2022-07-01 Steinhart Richard I Director RSU 付与(制限付株式) 72,156 - - 72,156
2022-07-01 Seth Sandesh Chief Executive Officer RSU 付与(制限付株式) 827,366 - - 827,366
2022-07-01 O'loughlin Steve Chief Financial Officer RSU 付与(制限付株式) 256,438 $4.96 $1.27M 256,348
2022-07-01 Nicholson, C. David Director RSU 付与(制限付株式) 72,156 - - 72,156
2022-07-01 Shetty Ajit Director RSU 付与(制限付株式) 72,156 - - 72,156
2022-07-01 Chell Jeffrey W. Director RSU 付与(制限付株式) 72,156 - - 72,156
2021-09-01 Steinhart Richard I Director RSU 付与(制限付株式) 18,351 $6.07 $111.39K 18,351
2021-09-01 Seth Sandesh Chief Executive Officer RSU 付与(制限付株式) 310,182 $6.07 $1.88M 310,182
2021-09-01 O'loughlin Steve Chief Financial Officer RSU 付与(制限付株式) 107,463 $6.07 $652.3K 107,463
2021-09-01 Nicholson, C. David Director RSU 付与(制限付株式) 18,351 $6.07 $111.39K 18,351
2021-09-01 Shetty Ajit Director RSU 付与(制限付株式) 18,351 $6.07 $111.39K 18,351
2021-09-01 Berger Mark Stanley Chief Medical Officer RSU 付与(制限付株式) 67,164 $6.07 $407.69K 67,164
2021-09-01 Chell Jeffrey W. Director RSU 付与(制限付株式) 18,351 $6.07 $111.39K 18,351
2020-08-12 Steinhart Richard I Director RSU 付与(制限付株式) 8,333 $9.55 $79.58K 8,333
2020-08-12 Seth Sandesh Chief Executive Officer RSU 付与(制限付株式) 139,062 $9.55 $1.33M 139,062
2020-08-12 O'loughlin Steve Chief Financial Officer RSU 付与(制限付株式) 59,066 $9.55 $564.08K 59,066
2020-08-12 Nicholson, C. David Director RSU 付与(制限付株式) 8,333 $9.55 $79.58K 8,333
2020-08-12 Shetty Ajit Director RSU 付与(制限付株式) 8,333 $9.55 $79.58K 8,333
2020-08-12 Berger Mark Stanley Chief Medical Officer RSU 付与(制限付株式) 46,667 $9.55 $445.67K 46,667
2020-08-12 Ludwig Dale L. Chief Science & Tech. Officer RSU 付与(制限付株式) 50,000 $9.55 $477.5K 50,000
2020-08-12 Chell Jeffrey W. Director RSU 付与(制限付株式) 8,333 $9.55 $79.58K 8,333
2019-07-12 Steinhart Richard I Director RSU 付与(制限付株式) 250,000 $0.23 $58K 250,000
2019-07-12 Seth Sandesh CEO RSU 付与(制限付株式) 1,500,000 $0.23 $348K 1,500,000
2019-07-12 O'loughlin Steve Principal Financial Officer RSU 付与(制限付株式) 400,000 $0.23 $92.8K 400,000
2019-07-12 Nicholson, C. David Director RSU 付与(制限付株式) 250,000 $0.23 $58K 250,000
2019-07-12 Shetty Ajit Director RSU 付与(制限付株式) 250,000 $0.23 $58K 250,000
2019-07-12 Berger Mark Stanley Chief Medical Officer RSU 付与(制限付株式) 400,000 $0.23 $92.8K 400,000
2019-07-12 Ludwig Dale L. Chief Scientific Officer RSU 付与(制限付株式) 400,000 $0.23 $92.8K 400,000
2019-07-12 Kapur Anil Chief Commercial Officer RSU 付与(制限付株式) 400,000 $0.23 $92.8K 400,000
2019-07-12 Chell Jeffrey W. Director RSU 付与(制限付株式) 250,000 $0.23 $58K 250,000
2019-03-05 Berger Mark Stanley Chief Medical Officer オプション行使(ITM) 3,500 $0.60 $2.1K 22,500
2019-02-21 Seth Sandesh Chairman & CEO オプション行使(ITM) 8,125 $0.60 $4.88K 161,458
2018-12-10 Seth Sandesh Chairman & CEO 情報に基づく買い 10,000 $0.44 $4.37K 153,333
情報付き — 公開市場取引(最も重要) 情報なし(買い) — 報酬・オプション行使・転換 情報なし(売り) — 源泉徴収・付与売却 中立 — 贈与・信託・失効
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る